Bradshaw urges generics industry to support user fees

Share this article:
Days after resigning to join the law firm of Hunton & Williams, FDA chief counsel Sheldon Bradshaw took advantage of his sudden freedom to strongly urge the generic drug industry to support user fees as the best means for reducing the review backlog at the agency. More funding for this from the administration is unlikely, he said.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters